• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
N-Acetyl-S-(N′-benzylthiocarbamoyl)-L-cysteine

N-Acetyl-S-(N′-benzylthiocarbamoyl)-L-cysteine

Product ID A0820
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $96.00 In stock
25 mg $189.00 In stock
100 mg $566.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

N-Acetyl-S-(N’-benzylthiocarbamoyl)-L-cysteine (ABITC) is a cysteine conjugate of N-acetyl-benzylisothiocyanate; acetylbenzyl isothiocyanate-L-cysteine is a derivative of benzyl isothiocyanate-L-cysteine (BITC). Isothiocyanates are typically found in plants of the Brassicaceae family, including broccoli, cabbage, and radish. Isothiocyanates are best known for their antioxidative, anticancer chemotherapeutic, chemopreventive, anti-angiogenic, and antibiotic properties. In vitro, BITC increases caspase-mediated apoptosis in Jurkat T cells. BITC also induces oxidative stress in glioma cells, inhibiting expression of superoxide dismutase and glutathione-S-transferase, resulting in cell cycle arrest and apoptosis. BITC downregulates expression of protein Ron, preventing growth of breast cancer stem cells in vitro and in vivo. Additionally, this compound inhibits mTOR activity, inducing autophagy in prostate cancer cells. In other in vitro models, BITC inhibits phosphorylation of VEGFR2 and downregulates expression of VEGF, HIF-1α, STAT3, and matrix metalloproteinase 2 (MMP2). BITC exhibits antibacterial activity against species of Bacillus, Staphylococcus, Enterococcus, Salmonella, and Enterobacter; it also displays anti-parasitic activity against nematodes of the genus Heterodera.

Product Info

Purity

≥98%

Formula

C13H16N2O3S2

Formula Wt.

312.41

IUPAC Name

(2R)-2-acetamido-3-(benzylcarbamothioylsulfanyl)propanoic acid

Synonym

Acetyl-benzylisothiocyanate-L-cysteine

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

A0820 MSDS PDF

Info Sheet

A0820 Info Sheet PDF

References

Dufour V, Stahl M, Rosenfeld E, et al. Insights into the mode of action of benzyl isothiocyanate on Campylobacter jejuni. Appl Environ Microbiol. 2013 Nov;79(22):6958-68. PMID: 24014524.

Ni WY, Hsiao YP, Hsu SC, et al. Oral administration of benzyl-isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375.S2 cells. In Vivo. 2013 Sep-Oct;27(5):623-6. PMID: 23988897.

Zhu Y, Zhuang JX, Wang Q, et al. Inhibitory effect of benzyl isothiocyanate on proliferation in vitro of human glioma cells. Asian Pac J Cancer Prev. 2013;14(4):2607-10. PMID: 23725183.

Kim SH, Sehrawat A, Singh SV. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo. Cancer Prev Res (Phila). 2013 Aug;6(8):782-90. PMID: 23661606.

Lin JF, Tsai TF, Liao PC, et al. Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling. Carcinogenesis. 2013 Feb;34(2):406-14. PMID: 23172666.

Boreddy SR, Sahu RP, Srivastava SK. Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3. PLoS One. 2011;6(10):e25799. PMID: 22016776.

Schroeder NE, Macguidwin AE. Mortality and behavior in Heterodera glycines juveniles following exposure to isothiocyanate compounds. J Nematol. 2010 Sep;42(3):194-200. PMID: 22736856.

Beevi SS, Mangamoori LN, Dhand V, et al. Isothiocyanate profile and selective antibacterial activity of root, stem, and leaf extracts derived from Raphanus sativus L. Foodborne Pathog Dis. 2009 Jan-Feb;6(1):129-36. PMID: 19182965.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F8147

    Fulvestrant

    Induces ER degradation.

    ≥98%
  • M4100

    MK-0524

    DP1 antagonist.

    ≥99%
  • Z4900

    ZM-447439 Trihydrate

    AurKA/B inhibitor.

    ≥99%
  • B5609

    Boc-GRR-AMC

    Peptide, protease substrate.

    ≥98%
  • L3374

    Lisinopril Dihydrate

    Enalapril analog; ACE inhibitor.

    ≥98%
  • P6264

    PPQ-102

    Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...

    ≥98%
  • Z161023

    β-Zearalanol

    Mycotoxin that has structural similarity to est...

    ≥98%
  • C9611

    Cyclosporin A

    Cyclic peptide; calcineurin inhibitor.

    ≥98%
  • I4962

    Isoimperatorin

    Furocoumarin; COX-2 inhibitor.

    ≥98%
  • D183745

    Destruxin B

    Cyclic depsipeptide is a secondary metabolite i...

    ≥96%
  • D3349

    Dimebon Dihydrochloride

    AMPK activator, L-type Ca2+ channel and NMDA, h...

    ≥98%
  • T5847

    Tolvaptan

    V2 antagonist.

    ≥99%
  • I088240

    (S,S)-ICG-001

    Wnt/β-catenin inhibitor

    ≥98%
  • E2003

    Efavirenz

    Non-nucleoside RT inhibitor.

    ≥99%
  • C9708

    CYC-116

    AurKB/C inhibitor.

    ≥98%
  • M3196

    MHY-1485

    mTOR activator.

    ≥98%
  • B3209

    Bicalutamide

    AR antagonist.

    ≥98%
  • S2792

    SGX-523

    MET inhibitor.

    ≥98%
  • O9334

    Oxibendazole

    Benzimidazole; microtubule polymerization inhib...

    ≥98%
  • O9234

    Oxiconazole Nitrate

    Imidazole; 14-α demethylase inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only